"True" weight-based dosing versus "flat" dosing of ribavirin: will the WIN-R please come forward?
Smith
Jason
J
Han
Steven-Huy B
SH
D001741:Black or African American; D000998:Antiviral Agents / Q000008:administration & dosage*; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*; D044465:White People
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b